Valuation: Repligen Corporation

Market Cap 7.89B 6.92B 6.39B 5.9B 11.19B 755B 11.41B 76.78B 29.83B 370B 29.62B 28.97B 1,283B P/E 2026 *
128x
P/E 2027 * 77.9x
Enterprise Value 7.63B 6.69B 6.18B 5.71B 10.83B 731B 11.04B 74.31B 28.87B 358B 28.66B 28.04B 1,242B EV / Sales 2026 *
9.33x
EV / Sales 2027 * 7.9x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day-1.72%
1 week-1.45%
Current month+0.40%
1 month+9.30%
3 months+14.37%
6 months-17.69%
Current year-16.40%
1 week 135.08
Extreme 135.08
144.58
1 month 124.85
Extreme 124.85
149.05
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 25.93
Extreme 25.93
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
06-25Sell

Chief Financial Officer

-733 0.0013%
05-14Free

Director

3,234 0.0057%
05-14Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.72%-1.45%+6.55%-4.49% 7.89B
-0.34%+3.47%-28.48%-10.88% 167B
-1.99%+3.51%-7.45%-5.17% 107B
+1.27%+6.91%+3.47%+59.91% 59.24B
-6.77%-7.86%+44.51%+46.55% 52.99B
-3.43%-1.28%-13.57%-41.40% 43.07B
-5.34%-2.29% - - 36.37B
+0.35%+6.96%-12.06%-43.61% 28.39B
-0.64%-3.26%+60.15%-6.41% 25.16B
-2.04%+1.90%-7.08%+5.37% 21.17B
Average -2.06%+4.73%+5.12%-0.01% 54.85B
Weighted average by Cap. -1.74%+5.22%-4.88%+1.06%

Financials

2026 *2027 *
Net sales 818M 718M 663M 612M 1.16B 78.35B 1.18B 7.97B 3.09B 38.34B 3.07B 3.01B 133B 943M 827M 764M 706M 1.34B 90.32B 1.36B 9.18B 3.57B 44.2B 3.54B 3.46B 153B
Net income 61.09M 53.58M 49.47M 45.71M 86.65M 5.85B 88.38M 595M 231M 2.86B 229M 224M 9.94B 101M 88.74M 81.93M 75.71M 143M 9.69B 146M 985M 383M 4.74B 380M 372M 16.46B
Net Debt -254M -223M -206M -190M -361M -24.36B -368M -2.48B -962M -11.92B -955M -935M -41.39B -432M -379M -350M -323M -613M -41.35B -625M -4.2B -1.63B -20.24B -1.62B -1.59B -70.25B
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
09/07/26 US$136.98 -2.04% 371,872
07/07/26 US$139.83 -1.15% 617,789
06/07/26 US$141.46 -0.66% 666,683
02/07/26 US$142.40 +2.45% 985,760
01/07/26 US$138.99 +1.87% 1,161,912
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
139.83USD
Average target price
177.05USD
Spread / Average Target
+26.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock